97 related articles for article (PubMed ID: 19327399)
21. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
22. Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development.
Groc L; Bezin L; Foster JA; Jiang H; Jackson TS; Weissmann D; Levine RA
Neurochem Int; 2001 Aug; 39(2):127-33. PubMed ID: 11408091
[TBL] [Abstract][Full Text] [Related]
23. Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications.
Louboutin JP; Strayer DS
ScientificWorldJournal; 2012; 2012():482575. PubMed ID: 22448134
[TBL] [Abstract][Full Text] [Related]
24. Role of the dopamine transporter in mediating the neuroleptic-induced reduction of tyrosine hydroxylase-immunoreactive midbrain neurons.
Reynolds KB; MacGillivray L; Zettler M; Rosebush PI; Mazurek MF
Brain Res; 2011 Jun; 1394():24-32. PubMed ID: 21396352
[TBL] [Abstract][Full Text] [Related]
25. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra.
Jiang H; Song N; Wang J; Ren LY; Xie JX
Neurochem Int; 2007 Jul; 51(1):32-6. PubMed ID: 17490790
[TBL] [Abstract][Full Text] [Related]
26. Effect of GP120 on glutathione peroxidase activity in cortical cultures and the interaction with steroid hormones.
Brooke SM; McLaughlin JR; Cortopassi KM; Sapolsky RM
J Neurochem; 2002 Apr; 81(2):277-84. PubMed ID: 12064474
[TBL] [Abstract][Full Text] [Related]
27. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
28. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
[TBL] [Abstract][Full Text] [Related]
29. Toxic influence of chronic oral administration of paraquat on nigrostriatal dopaminergic neurons in C57BL/6 mice.
Ren JP; Zhao YW; Sun XJ
Chin Med J (Engl); 2009 Oct; 122(19):2366-71. PubMed ID: 20079141
[TBL] [Abstract][Full Text] [Related]
30. Role of Oxidative Stress in HIV-1-Associated Neurocognitive Disorder and Protection by Gene Delivery of Antioxidant Enzymes.
Louboutin JP; Strayer D
Antioxidants (Basel); 2014 Nov; 3(4):770-97. PubMed ID: 26785240
[TBL] [Abstract][Full Text] [Related]
31. Progressive loss of dopaminergic neurons induced by unilateral rotenone infusion into the medial forebrain bundle.
Norazit A; Meedeniya AC; Nguyen MN; Mackay-Sim A
Brain Res; 2010 Nov; 1360():119-29. PubMed ID: 20807515
[TBL] [Abstract][Full Text] [Related]
32. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
[TBL] [Abstract][Full Text] [Related]
33. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
[TBL] [Abstract][Full Text] [Related]
34. Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat.
Rodríguez VM; Limón-Pacheco JH; Mendoza-Trejo MS; González-Gallardo A; Hernández-Plata I; Giordano M
Neurotoxicology; 2013 Jan; 34():82-94. PubMed ID: 23123945
[TBL] [Abstract][Full Text] [Related]
35. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation.
Kim SR; Chung ES; Bok E; Baik HH; Chung YC; Won SY; Joe E; Kim TH; Kim SS; Jin MY; Choi SH; Jin BK
J Neurosci Res; 2010 May; 88(7):1537-48. PubMed ID: 20025058
[TBL] [Abstract][Full Text] [Related]
36. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Bartus RT; Brown L; Wilson A; Kruegel B; Siffert J; Johnson EM; Kordower JH; Herzog CD
Neurobiol Dis; 2011 Oct; 44(1):38-52. PubMed ID: 21704161
[TBL] [Abstract][Full Text] [Related]
37. Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism.
Zhao F; Cai T; Liu M; Zheng G; Luo W; Chen J
Toxicol Sci; 2009 Jan; 107(1):156-64. PubMed ID: 18836210
[TBL] [Abstract][Full Text] [Related]
38. LPS-induced degeneration of dopaminergic neurons of substantia nigra in rats.
Li G; Sun S; Cao X; Zhong J; Tong E
J Huazhong Univ Sci Technolog Med Sci; 2004; 24(1):83-6. PubMed ID: 15165124
[TBL] [Abstract][Full Text] [Related]
39. The role of Ret receptor tyrosine kinase in dopaminergic neuron development.
Li L; Su Y; Zhao C; Zhao H; Liu G; Wang J; Xu Q
Neuroscience; 2006 Oct; 142(2):391-400. PubMed ID: 16879925
[TBL] [Abstract][Full Text] [Related]
40. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons.
Keswani SC; Polley M; Pardo CA; Griffin JW; McArthur JC; Hoke A
Ann Neurol; 2003 Sep; 54(3):287-96. PubMed ID: 12953261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
